drugset / Trial / NCT01209195
A Study of MM-121 in Combination With Paclitaxel in Patients With Advanced Gynecologic and Breast Cancers
NaSingle-groupOpen-labelTreatment
Summary
This study was a Phase 1 and pharmacologic open-labeled dose-escalation trial of MM-121 in combination with paclitaxel using a "3+3" design.
Timeline
- Start
- 2010-10
- Primary completion
- 2014-05
- Completion
- 2014-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Seribantumab | Monoclonal antibody | — | Intravenous |
| Background | Paclitaxel | Small molecule | 80 mg/m2 | Intravenous |